Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Cytokine. 2020 Nov 19;138:155360. doi: 10.1016/j.cyto.2020.155360

Table 4-.

Saliva concentrations of selected cytokines at baseline.

Saliva pg/mL Control Median
(25%-75%)
NG+GP Median
(25%-75%)
PD+GP Median
(25%-75%)
T2DM+GP Median
(25%-75%)
p-value*
IL-1β 23.08 (8.75; 38.5) A 92.63 (46.12; 159) B 125 (51.7; 209.2) B 90.3 (48.7; 141.9) B <0.01
IL-2 6.8 (2.9; 8.4) A 10.8 (6.36; 35.3) A 11.9 (9.3; 17.9) A 8.2 (4.3; 14.8) A 0.19
IL-6 8.15 (4; 16.07) A 12.7 (8.8; 37.3) A 14.8 (6.7; 28.8) A 11.05 (6.05; 14.9) A 0.26
IL-8 1504.6 (455.5; 2217.2) A 2092 (766.2; 3835.2) A 3527.5 (1083.2; 10630.1) A 3615.4 (1046.8; 13517.4) A 0.15
IL-5 0.7 (0.43; 1.38) A 1.65 (0.55; 18.2) A 1.92 (1.03; 2.4) A 0.49 (0.3; 1.9) A 0.03
IL-4 3.27 (2.37; 4.53) A 5.9 (4.5; 62.8) AB 8.2 (6.3; 15.8) B 6.8 (1.5; 12.06) AB 0.02
IL-10 1.34 (0.99; 3.88) A 3.13 (1.83; 21.5) A 4.15 (2.27; 6.78) A 4.95 (0.8; 11) A 0.28
IFN-γ 0.34 (0.01; 1.14) A 0.3 (0.01; 6.9) A 0.6 (0.3; 1.05) A 0.11 (0.01; 0.75) A 0.53
GM-CSF 3.46 (0.96; 7.26) A 4.78 (2.9; 17) A 6.26 (2.7; 12.8) A 2.38 (1.44; 12) A 0.62
TNF-α 6.6 (2.4; 8.3) A 11.5 (7.3; 50) B 14 (8.3; 23.1) B 10.5 (3.9; 18.4) B 0.01
*

Different letters denote statistically different groups (Kruskall Wallis followed by Dunn test with Bonferroni correction).

NG, normoglycemic; PD, pre-diabetes; T2DM, type 2 diabetes mellitus; GP, generalized periodontitis.